Generation and Next-Generation Sequencing-Based Characterization of a Large Human Combinatorial Antibody Library
International Journal of Molecular Sciences · 2023
DOI: 10.3390/ijms24066011 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Journal of Molecular Sciences, 2023. Verfasst von Hye Lim Choi und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Biopharmaceutical Chemistry, Kookmin University, Seoul 02707, Republic of Korea. Hauptthemen laut MEDLINE: Peptide Library, Epstein-Barr Virus Infections. Die Arbeit wurde bisher 10-mal zitiert (Crossref) und nennt 56 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Korea Health Technology R&D Project of the Korea Health Industry Development Institute, Korea Health Technology R&D Project of the Korea Health Industry Development Institute.
Abstract (Originalsprache)
Antibody phage display is a key technology for the discovery and development of target-specific monoclonal antibodies (mAbs) for use in research, diagnostics, and therapy. The construction of a high-quality antibody library, with larger and more diverse antibody repertoires, is essential for the successful development of phage display-derived mAbs. In this study, a large human combinatorial single-chain variable fragment library (1.5 × 1011 colonies) was constructed from Epstein–Barr virus-infected human peripheral blood mononuclear cells stimulated with a combination of two of the activators of human B cells, the Toll-like receptor 7/8 agonist R848 and interleukin-2. Next-generation sequencing analysis with approximately 1.9 × 106 and 2.7 × 106 full-length sequences of heavy chain variable (VH) and κ light chain variable (Vκ) domains, respectively, revealed that the library consists of unique VH (approximately 94%) and Vκ (approximately 91%) sequences with greater diversity than germline sequences. Lastly, multiple unique mAbs with high affinity and broad cross-species reactivity could be isolated from the library against two therapeutically relevant target antigens, validating the library quality. These findings suggest that the novel antibody library we have developed may be useful for the rapid development of target-specific phage display-derived recombinant human mAbs for use in therapeutic and diagnostic applications.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Biopharmaceutical Chemistry, Kookmin University, Seoul 02707, Republic of Korea.
- Department of Chemistry, Kookmin University, Seoul 02707, Republic of Korea.
- ATG Lifetech Inc., Seoul 08507, Republic of Korea.
- Department of Applied Chemistry, Kookmin University, Seoul 02707, Republic of Korea.
- Antibody Research Institute, Kookmin University, Seoul 02707, Republic of Korea.
ORCID-Profile: Kyusang Hwang, Ji Woong Kim, Sukmook Lee
Förderung
- Korea Health Technology R&D Project of the Korea Health Industry Development Institute
- Korea Health Technology R&D Project of the Korea Health Industry Development Institute
Zitieren
APA
Choi, H. L., Yang, H. R., Shin, H. G., Hwang, K., Kim, J. W., Lee, J. H., Ryu, T., Jung, Y., & Lee, S. (2023). Generation and Next-Generation Sequencing-Based Characterization of a Large Human Combinatorial Antibody Library. International Journal of Molecular Sciences. https://doi.org/10.3390/ijms24066011
Vancouver
Choi HL, Yang HR, Shin HG, Hwang K, Kim JW, Lee JH, et al. Generation and Next-Generation Sequencing-Based Characterization of a Large Human Combinatorial Antibody Library. International Journal of Molecular Sciences. 2023. doi:10.3390/ijms24066011
BibTeX
@article{Choi2023,
author = {Choi, Hye Lim and Yang, Ha Rim and Shin, Ha Gyeong and Hwang, Kyusang and Kim, Ji Woong and Lee, Ji Hyun and Ryu, Taehoon and Jung, Yushin and Lee, Sukmook},
title = {Generation and Next-Generation Sequencing-Based Characterization of a Large Human Combinatorial Antibody Library},
journal = {International Journal of Molecular Sciences},
year = {2023},
doi = {10.3390/ijms24066011}
}
EUVIMED